NTAKα and β isoforms stimulate breast tumor cell growth by means of different receptor combinations

Norihiko Nakano, Shigeki Higashiyama, Kenichi Kajihara, Takeshi Endo, Hiroshi Ishiguro, Kouji Yamada, Toshiharu Nagatsu, Naoyuki Taniguchi

Research output: Contribution to journalArticlepeer-review

12 Citations (Scopus)


Neural- and thymus-derived activator for ErbB kinases (NTAK) is a recently described member of the neuregulin family that binds directly to ErbB3 and ErbB4 and transactivates ErbB2. Rat NTAK has at least five alternative-spliced isoforms: α1, α2a, α2b, β, and γ. In order to understand their biological properties, this study focused on the NTAKα2a and β isoforms, which have different EGF-like domains. The effect of these isoforms on cell growth and tyrosine phosphorylation in human breast cancer cells, MDA-MB-453 and T47D, was examined using the recombinant proteins. In terms of cell growth, NTAKα2a and NTAKβ preferentially stimulate T47D cells and MDA-MB-453 cells, respectively, in a dose-dependent manner. Although both NTAKs induce the highest level of tyrosine phosphorylation of ErbB2, NTAKα2a and NTAKβ preferentially induce ErbB3 and ErbB4 phosphorylation, respectively. Thus, NTAKα2a and NTAKβ stimulate cell growth in different ways, by means of different combinations of receptors.

Original languageEnglish
Pages (from-to)925-930
Number of pages6
JournalJournal of Biochemistry
Issue number5
Publication statusPublished - 2000

All Science Journal Classification (ASJC) codes

  • General Medicine


Dive into the research topics of 'NTAKα and β isoforms stimulate breast tumor cell growth by means of different receptor combinations'. Together they form a unique fingerprint.

Cite this